Correlation Between NYSE Composite and Relief Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Relief Therapeutics Holding, you can compare the effects of market volatilities on NYSE Composite and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Relief Therapeutics.
Diversification Opportunities for NYSE Composite and Relief Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and Relief is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Relief Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Relief Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.32 times less return on investment than Relief Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 10.01 times less risky than Relief Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,140 in Relief Therapeutics Holding on September 1, 2024 and sell it today you would lose (604.00) from holding Relief Therapeutics Holding or give up 52.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.78% |
| Values | Daily Returns |
NYSE Composite vs. Relief Therapeutics Holding
Performance |
| Timeline |
NYSE Composite and Relief Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Relief Therapeutics Holding
Pair trading matchups for Relief Therapeutics
Pair Trading with NYSE Composite and Relief Therapeutics
The main advantage of trading using opposite NYSE Composite and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.| NYSE Composite vs. Acumen Pharmaceuticals | NYSE Composite vs. Mind Medicine | NYSE Composite vs. NL Industries | NYSE Composite vs. Ecovyst |
| Relief Therapeutics vs. Analog Devices | Relief Therapeutics vs. Entegris | Relief Therapeutics vs. NioCorp Developments Ltd | Relief Therapeutics vs. Vindicator Silver Lead Mining |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |